Drugs that stimulate the next subtype, the 5-HT2B receptor, have been associated with heart valve disease, the major reason for withdrawal of the fenfluramine part of the fen-phen weight loss combination drug.
FORBES: Why Does Arena's Obesity Drug Have Abuse Potential?